Search

Search Constraints

You searched for: Author/Creator Detti, B.

Search Results

3. Toxicity after moderately hypofractionated versus conventionally fractionated prostate radiotherapy: A systematic review and meta-analysis of the current literature. (September 2021)

4. PO-1393 ARTO (NCT03449719), quality of life monocentric report after stereotactic treatment and abiraterone. (August 2021)

5. PD-0849 Concomitant Nivolumab and RT in metastatic kidney cancer. Benefit of ablative vs palliative approach. (August 2021)

6. PO-1316 Stereotactic radiotherapy in recurrent prostate cancer after postoperative or definitive irradiation. (August 2021)

8. Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis. Issue 1 (January 2022)

9. Stereotactic Re-irradiation in Recurrent Prostate Cancer after Previous Postoperative or Definitive Radiotherapy: Long-term Results after a Median Follow-up of 4 Years. Issue 1 (January 2022)

10. PO-1366 Pattern of recurrence after SBRT in prostate cancer patients with nodal pelvic relapse. (August 2021)